256 related articles for article (PubMed ID: 27145367)
1. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.
Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH
Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367
[TBL] [Abstract][Full Text] [Related]
2. Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties.
Im CN; Yun HH; Lee JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241425
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
4. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
[TBL] [Abstract][Full Text] [Related]
5. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
[TBL] [Abstract][Full Text] [Related]
6. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
7. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling.
Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang X; Wang C
Biochem Biophys Res Commun; 2021 Mar; 544():73-80. PubMed ID: 33524871
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
9. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
[TBL] [Abstract][Full Text] [Related]
11. Methylation by EZH2 activates STAT3 in glioblastoma.
Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
[TBL] [Abstract][Full Text] [Related]
12. Combination Treatment with PPAR
Im CN
Biomed Res Int; 2017; 2017():5832824. PubMed ID: 28642874
[TBL] [Abstract][Full Text] [Related]
13. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
15. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
Rath BH; Wahba A; Camphausen K; Tofilon PJ
Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
[TBL] [Abstract][Full Text] [Related]
16. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
[TBL] [Abstract][Full Text] [Related]
17. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
18. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
19. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
[TBL] [Abstract][Full Text] [Related]
20. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K
Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]